Evidence map›Paper›PMID 37981867›Full record

ArticleLab on a chip2023

A human initial lymphatic chip reveals distinct mechanisms of primary lymphatic valve dysfunction in acute and chronic inflammation.

Samantha Kraus, Esak Lee

Open access · greenAbstract read
In one paragraph

Article in Lab on a chip, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Samantha KrausNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA. el767@cornell.edu.
Esak LeeNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA. el767@cornell.edu.ORCID 0000-0002-5328-6677
Cornell University · US

Funding

Regulation of Lymphatic Endothelial Cell Junction and DrainageR01HL165135 · NHLBI · CORNELL UNIVERSITY · PI Esak Lee · 2022 to 2026
$2.5M
Tissue-Engineered Models of Lymphatic Drainage in Breast CancerR01CA279560 · NCI · CORNELL UNIVERSITY · PI Esak Lee · 2023 to 2026
$1.6M
High-throughput nanoIEA-based Assay for Screening Immune Cell-Vascular InteractionsR21AI168886 · NIAID · CORNELL UNIVERSITY · PI KIM, DEOK-HO, LEE, ESAK · 2023 to 2024
$450k
A Bioengineered Model for Deciphering Lymphatic Dysfunction in InflammationR21AI166772 · NIAID · CORNELL UNIVERSITY · PI LEE, ESAK · 2021 to 2022
$400k
NCI NIH HHS R01 CA279560NHLBI NIH HHS R01 HL165135NIAID NIH HHS R21 AI166772NIAID NIH HHS R21 AI168886
6 · The paper itself

Abstract

Interstitial fluid uptake and retention by lymphatic vessels (LVs) play a role in maintaining interstitial fluid homeostasis. While it is well-established that intraluminal lymphatic valves in the collecting LVs prevent fluid backflow (secondary lymphatic valves), a separate valve system in the initial LVs that only permits interstitial fluid influx into the LVs, preventing fluid leakage back to the interstitium (primary lymphatic valves), remains incompletely understood. Although lymphatic dysfunction is commonly observed in inflammation and autoimmune diseases, how the primary lymphatic valves are affected by acute and chronic inflammation has scarcely been explored and even less so using

Indexed as

Lymphatic VesselsTumor Necrosis Factor-alphaBiological TransportFibrillinsHumansInflammationFibrillinsTumor Necrosis Factor-alpha

Identifiers

PMID37981867
PMCPMC10908576
OpenAlexW4388677276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.